Medication info
Dapagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Dapagliflozin 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Yellow, film-coated tablet with a convex diamond shape on both sides
Packaging
Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle, Box - 28 tablets/box [7 tablets/Alu-Alu x 4]
Approval status
Active

MFDS item code 202200034 · Approved 2022.01.04 · Insurance code 657308650

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus; treatment of chronic heart failure; prevention of worsening chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior antidiabetic drug treatment, the recommended initial dose of this medication when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medication is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medication is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus; treatment of chronic heart failure; prevention of worsening chronic kidney disease

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular diseases
  • cardiovascular risk factors
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • decreased glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes and is administered alone or in combination with diet and exercise therapy. It also helps reduce the risk of death and hospitalization related to cardiovascular disease in patients with chronic heart failure. In patients with chronic kidney disease, it lowers the risk of worsening kidney function and contributes to reducing mortality from cardiovascular disease. This medication maximizes efficacy when used alongside standard treatments. Overall, it is used to improve blood sugar, cardiovascular, and kidney health.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior antidiabetic drug treatment, the recommended initial dose of this medication when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medication is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medication is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those on dialysis. Caution is required for patients with reduced fluid volume or impaired kidney function, and blood pressure and kidney function should be closely monitored before and during administration. Special care is needed for the elderly or patients on diuretics due to a higher risk of hypotension or fluid depletion. This medication is not recommended for patients with severely impaired kidney function, and those with very low kidney function should be cautious as experience with this medication is limited. Infections of the genitals or urinary tract may occur while taking this medication, so if any symptoms of infection appear, consult a healthcare professional immediately. There is a risk of hypoglycemia, so dosage adjustments may be necessary when used alongside insulin or sulfonylureas. Dehydration or hypotension symptoms may occur due to reduced fluid volume, especially in cases of fluid loss from gastrointestinal diseases. Serious metabolic disturbances such as diabetic ketoacidosis can occur; seek immediate medical attention if symptoms such as vomiting, abdominal pain, or shortness of breath arise. It is advisable for women who are pregnant or nursing not to use this medication, and administration should be halted if pregnancy is confirmed. The safety and efficacy of this medication have not been established in children, thus it is not used in this population. In cases of overdose, there is no specific antidote, and symptomatic treatment is required; in severe cases, appropriate symptomatic treatment in a hospital is necessary. While taking this medication, it is generally safe to drive or operate machinery, but caution is needed if there is a risk of hypoglycemia.

Side effects

vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased creatinine clearance in the early treatment phase, dyslipidemia, elevated serum creatinine in the early treatment phase, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory abnormalities, cerebral infarction, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, chest pain, ligament sprain, road traffic accident, drug overdose, ankle fracture, hand fracture, pelvic fracture, meniscus injury, thoracic vertebral fracture, tibial fracture, erythrocytosis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased serum lactate, lymphocytopenia, vitamin D deficiency, decreased appetite, fatigue, headache, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like syndrome, vaginal discharge, itching, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, dry eye, eye pain, retinal disorders, decreased vision, blepharitis, cataract, conjunctival swelling, allergic conjunctivitis, conjunctivitis, diplopia, eyelid swelling, keratitis, increased intraocular pressure, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to store the medication at room temperature between 1°C and 30°C, away from extreme heat or cold.

Appearance and packaging

Appearance

Yellow, film-coated tablet with a convex diamond shape on both sides

Package unit

Bottle - 28 tablets/bottle, Bottle - 30 tablets/bottle, Box - 28 tablets/box [7 tablets/Alu-Alu x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.